You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
Shares of Bristol Myers Squibb fell modestly after the drugmaker's better-than-expected first-quarter results.
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.